GSK_ Annual_Report_2021-22

17 Performance Summary (Amounts in ` Lakhs) 2021-22# 2020-21# 2019-20# 2018-19# 2017-18# 2016-17# 2015-16# 15 Months Ended March 2015# 2013 2012 (Refer Note 1) (Refer Note 1) (Refer Note 5) PROFIT AND LOSS ACCOUNT Revenue from Operations 3217,51 2920,48 3224,68 3128,53 2895,88 2994,51 2826,21 3362,36 2619,37 2700,34 Profit before exceptional items and tax 761,87 625,83 646,99 658,82 523,78 465,35 573,63 766,84 703,17 994,78 Exceptional items 11,58 (172,60) (324,49) 4,89 17,80 45,73 2,31 (51,88) 26,15 148,22 Profit Before Tax 773,44 453,23 322,50 663,71 541,58 511,08 575,94 714,96 729,32 1143,00 Profit for the Period 376,58 286,69 110,05 425,36 351,98 336,78 374,53 449,90 501,88 577,26 BALANCE SHEET Equity share capital 169,41 169,41 169,41 169,41 84,70 84,70 84,70 84,70 84,70 84,70 Other Equity 2508,21 1327,71 1670,63 1973,01 1995,25 1943,51 2119,94 2382,38 1932,49 1925,31 Borrowings - 2 18 58 99 1,60 2,37 2,48 4,14 4,59 2677,62 1497,14 1840,22 2143,00 2080,94 2029,81 2207,02 2469,57 2021,33 2014,60 Property, Plant and Equipment, Intangible Assets and CWIP 359,94 398,77 876,71 1432,63 1245,71 858,17 471,71 238,28 161,93 133,19 Investments including investment properties 25,68 25,82 25,97 26,17 49,43 52,99 53,63 53,80 57,67 102,58 Deferred tax assets (net) 112,78 101,67 108,85 60,48 103,05 91,31 100,81 94,83 92,11 86,54 Net Assets (Current and Non- Current) 2179,22 970,88 828,69 623,72 682,75 1027,33 1580,87 2082,65 1709,62 1692,29 2677,62 1497,14 1840,22 2143,00 2080,94 2029,81 2207,02 2469,57 2021,33 2014,60 OTHER KEY DATA Equity Share of ` 10/- each Dividend 30.00 30.00 20.00 20.00 17.50 15.00 25.00 31.25 25.00 25.00 Special Additional Dividend 60.00 0.00 20.00 - - - - - - - Total Dividend (Refer Note 2) 90.00 30.00 40.00 20.00 17.50 15.00 25.00 31.25 25.00 25.00 Earnings per equity share (Refer Note 2 and Note 3) 99.79 21.11 6.50 25.11 20.78 19.88 22.11 26.56 29.63 34.08 Book Value (Refer Note 2) 158.06 88.37 108.62 126.46 122.78 119.72 130.14 145.63 119.08 118.65 Number of employees 3840 4323 4364 4960 4620 4697 4611 4657 5034 4706 # Period 15 Months Ended March 2015, Year 2015-16, 2016-17, 2017-18, 2018-19, 2019-20,2020-21 and 2021-22 are prepared in accordance with Indian Accounting Standards (“Ind-AS”) and for other years it is prepared as per Indian Generally Accepted Accounting Principles (“IGAAP”) NOTES :- 1. The profit and loss statement for the period ended 2021-22 represents continuing operations of the business and 2020-21 have been recasted to reflect the same in accordance with the requirements of Ind AS105 consequent to the sale of certain brands and other identified assets. Hence they are not comparable with prior years. 2. Dividend, Earning per equity share and Book Value have been retrospectively adjusted for September 2018 bonus issue for all the prior years. 3. Without considering exceptional items, Earnings per equity share for the period 2021-22, 2020-21 and 2019-20 would be ` 99.05, ` 31.32 and ` 26.69 respectively 4. Figures have been adjusted/regrouped wherever necessary in line with the financial statements, to facilitate comparison. 5. The accounting year of the company has been changed from January - December to April - March with effect from Mar 2015. Consequently, financial statements from 1st January, 2014 to 31st March, 2015 are for 15 months.